Home » Stocks » Innovation Pharmaceuticals

Innovation Pharmaceuticals Inc. (IPIX)

Stock Price: $0.201 USD -0.009 (-4.52%)
Updated Oct 22, 2020 1:35 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 68.89M
Revenue (ttm) 423,000
Net Income (ttm) -6.65M
Shares Out 343.58M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 22, 2020
Last Price $0.201
Previous Close $0.210
Change ($) -0.009
Change (%) -4.52%
Day's Open 0.202
Day's Range 0.200 - 0.205
Day's Volume 567,646
52-Week Range 0.05 - 0.65

More Stats

Market Cap 68.89M
Enterprise Value 65.33M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 343.58M
Float 314.41M
EPS (basic) -0.03
EPS (diluted) -0.03
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.20
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 162.86
PB Ratio 49.37
Revenue 423,000
Operating Income -4.64M
Net Income -6.65M
Free Cash Flow -4.16M
Net Cash 3.56M
Net Cash / Share 0.01
Gross Margin 100.00%
Operating Margin -1,095.74%
Profit Margin -1,571.60%
FCF Margin -982.51%
ROA -43.58%
ROE n/a
ROIC 128.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit0.42---------
Operating Income-4.64-6.45-13.94-15.34-12.65-12.96-8.04-2.98-4.20-5.72
Net Income-6.65-8.68-16.36-15.54-12.85-13.15-8.25-3.22-4.89-5.94
Shares Outstanding23717814512712011510594.9890.1690.30
Earnings Per Share-0.03-0.05-0.11-0.12-0.11-0.11-0.10-0.04-0.06-0.06
Operating Cash Flow-4.16-6.33-13.28-11.71-9.89-13.07-7.51-1.91-0.69-0.74
Capital Expenditures-0.040.01-0.06-0.07-0.01-0.02---
Free Cash Flow-4.16-6.29-13.27-11.77-9.96-13.08-7.53-1.91-0.69-0.74
Cash & Equivalents6.020.582.424.146.318.414.992.960.030.07
Total Debt2.461.922.
Net Cash / Debt3.56-1.340.402.124.296.392.970.93-1.99-2.45
Book Value1.46-4.13-2.15-1.462.967.021.21-5.17-7.63-7.29
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Innovation Pharmaceuticals Inc.
Country United States
Employees 4
CEO Leo Ehrlich

Stock Information

Ticker Symbol IPIX
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: IPIX


Innovation Pharmaceuticals, a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. It develops Brilacidin, a lead drug compound for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company also develops Kevetrin, a lead anti-cancer compound for treating ovarian cancer. It has license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.